COMPASS PATHWAYS PLC Interest Expense
COMPASS PATHWAYS PLC (CMPS) reported Interest Expense of $1.10 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-08
- COMPASS PATHWAYS PLC interest expense for the quarter ending 2024-03-31 was $1.10M.
- COMPASS PATHWAYS PLC interest expense for the quarter ending 2023-12-31 was $1.12M.
- COMPASS PATHWAYS PLC interest expense for the quarter ending 2023-09-30 was $1.08M.
- COMPASS PATHWAYS PLC interest expense for the quarter ending 2023-03-31 was $0.00.
- COMPASS PATHWAYS PLC interest expense for fiscal 2023 was $2.20M.
- COMPASS PATHWAYS PLC interest expense for fiscal 2022 was $0.00.
- COMPASS PATHWAYS PLC interest expense for fiscal 2021 was $0.00.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $1.10M 10-Q · filed 2024-05-08 | $2.22M derived: sum of 2 quarters · filed 2024-05-08 | $3.30M derived: sum of 3 quarters · filed 2024-05-08 | |
| 2023-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.20M derived: sum of 2 quarters · filed 2024-02-29 | $2.20M 10-K · filed 2024-02-29 | |
| 2023-09-30 | $1.08M 10-Q · filed 2023-11-02 | $1.08M 10-Q · filed 2023-11-02 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2024-05-08 | $0.00 derived: sum of 3 quarters · filed 2024-05-08 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | ||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |